Obesity linked to higher risk of prostate cancer progression

	Tweet

Even when treated with hormone therapy to suppress tumor growth, obese men face an elevated risk of their prostate cancer worsening, researchers at Duke University Medical Center have found.

The research, reported at the American Urological Association annual meeting Sunday (May 15, 2011), advances the link between obesity and prostate cancer, which has generated research interest in recent years as the incidence of both conditions remains high and often overlaps.

“Over the past decades, there has been increasing prevalence of obesity in the U.S. and Europe, and a high rate of prostate cancer that is the second-most lethal cancer for men,” said Christopher J. Keto, M.D., a urologic fellow at Duke University Medical Center and lead author of the study.

An estimated one in six U.S. men will be diagnosed with prostate cancer during his lifetime, according to the American Cancer Society; additionally, one in three U.S. men are obese.

To examine the role obesity may play in prostate cancer, Keto and colleagues at Duke identified 287 men whose diseased prostates had been removed at five U.S. Department of Veteran Affairs hospitals from 1988-2009.

Because their cancers had reappeared, the men had also been given androgen deprivation therapy (ADT). The chemical inhibits production of the male hormone testosterone, which fuels prostate tumors.

Men in the study group who were overweight or obese had a three-fold increased risk of cancer progression compared to normal-weight men, despite receiving the same treatment.

Additionally, overweight men had more than a three-fold increased risk of their cancer spreading to the bone compared to normal-weight men, while obese men had a five-fold increase in the risk of metastases.

Keto said additional studies are needed to determine why heavy men fare worse than normal-weight men, even when treated similarly. One area of scrutiny may be the dosage of ADT.

“We think perhaps obese men may require additional ADT,” Keto said. “The dose is the same regardless of weight, while most drugs are dosed according to weight.”

Stephen J. Freedland, M.D., associate professor of urology in the Duke Prostate Cancer Center and senior author of the study, said the findings build upon the Duke group’s broader research efforts into the connection between obesity and prostate cancer.

“By being thematic in our research we can really get to the bottom of something,” Freedland said. “The study supports a growing body of literature showing that obese men with prostate cancer do worse. Our next step is to figure out why.”

Freedland said knowing that heavy men are at higher risk for bad outcomes could lead to better interventions. He said the Duke group has launched a new trial to test the effects of diet and exercise on overweight and obese men whose prostate cancer treatment includes hormone therapy.

“If obesity is bad for prostate cancer, we may have to be more aggressive in our treatment,” he said. “Ultimately, we aim to learn why, which in turn can lead us to better treatments for these men.”

###

In addition to Keto and Freedland, study authors included William J. Aronson, M.D.; Martha K. Terris, M.D.; Joseph C. Presti, M.D.; Christopher J. Kane, M.D.; and Christopher L. Amling, M.D.

The study was funded by the Department of Defense, U.S. Department of Veterans Affairs, the National Institutes of Health, and the AUA Foundation/Astellas Rising Star Award.

###

Contact: Sarah Avery

919-660-1306
Duke University Medical Center

RELATED STORIES:
Study Drug Holds Promise As Alternative to Castration For Early Prostate Cancers   Prostate technique provides new insights   Vaccine Approach Extends Life of Metastatic Prostate Cancer Patients   Obesity-linked High Blood Volumes Render PSA Prostate Cancer Test Less Effective   New technique in robot-assisted laparoscopic prostatectomy   U.S. task force: End routine prostate cancer screening   Freezing prostate cancer does a man’s body good   New, Non-invasive Prostate Cancer Test Beats PSA in Detecting Prostate Cancer   Gene test could save men from prostate surgery   Drug shows promise in prostate cancer spread to bone   Red, processed meats linked to prostate cancer   Carcinoma of the Prostate Treatment   A Better Blood Test for Prostate Cancer   Prostate cancer risk increased in obese men: study   Study examines the use of a novel suprapubic catheter in suprapubic prostatectomy   Biomarkers Help Predict Prostate Cancer Progression   Black men least likely to get prostate cancer screening even during peak ages of risk   Botox relieves BPH symptoms   Prostate test ‘public health disaster’ - discoverer   Higher vitamin K intake tied to lower cancer risks   New diagnostic tool for prostate cancer   PSA levels accurately predict prostate cancer risk in African-American men

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]